• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Pathogenesis of Metastatic Bone Lesion and Development of Methods for Its Diagnosis and Treatment

Research Project

Project/Area Number 06454343
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field 内分泌・代謝学
Research InstitutionJapanese Foundation for Cancer Research

Principal Investigator

OGATA Etsuro  Cancer Institute, Chief, 部長 (70013761)

Co-Investigator(Kenkyū-buntansha) TAKAHASHI Shunji  Cancer Chemotherapy Center, Senior Investigator, 研究員 (90221358)
SEKINE Imao  Cancer Institute, Senior Investigator, 研究員 (10134602)
MATSUMOTO Toshio  University of Tokyo, 4th Dept.of Internal Medicine, Lecturer, 医学部, 講師 (20157374)
Project Period (FY) 1994 – 1996
Keywordsbone metastasis / integrin / bone resorption / osteoclast / annexin / bisphosphonate / bone metabolic marker
Research Abstract

In order to clarify the mechanism of develoment as well as to establish methods for the diagnosis and treatment of metastatic bone lesions, the following studies were performed :
1.Effects of adhesion of tumor cells to bone matrix and stromal cells : Many tumor cells that have metastatic potential express alpha4beta1 integrin, and bone marrow stromal cells (BMSC) constitutively express vascular cell adhesion molecule (VCAM)-1 that can bind to alpha4beta1 integrin. We have demonstrated that anti-VCAM-1 or anti-alpha4beta1 integrin antibody can inhibit adhesion of clonal melanoma cells, B16, to BMSC,and that the inhibition of adhesion by these antibodies blocks the adhesion-induced inhibition of BMSC differentiation into osteoblasts. The adhesion of B16 cells with BMSC also enhanced osteoclast formation supported by BMSC.Furthermore, pretreatment with anti-VCAM-1 or anti-alpha4beta1 integrin antibody caused an inhibition of osteoclast formation enhanced by the adhesion of B16 cells. These … More results demonstrate that adhesion of tumor cells with BMSC via the binding of alpha4beta1 integrin with BMSC causes not only the inhibition of osteoblastic differentiation but also the stimulation of osteoclast formation. These changes caused by the adhesion of tumor cells with BMSC may play an important role in the establishment and expansion of metastatic bone lesions.
2.Role of annexin II on the stimulation of bone resorption by tumor cells : We have cloned cDNA for human annexin II as a stimulatory factor of osteoclast formation, and established a breast cancer cell line over expressing annexin ii. We now have established cell lines that stably express antisense annexin II RNA to block the expression of annexin II.Using these cell lines, we are in the process of analyzing the effect of co-culture of these cell lines with bone marrow cells on osteoclast formation and bone resorption. These studies should enable us to clarify the role of annexin II produced by tumor cells on the enhancement of bone resorption at metastatic bone lesions.
3.Effect of bone metastasis on bone turnover : The effect of bisphosphonates, a potent inhibitor of bone resorption, on the development of metastatic bone lesions was examined. These was a significant correlation between the inhibition of bone resorption assessed by bone metabolic markers and the extent of metastatic lesions assessed by tumor markers. These results suggest that inhibition of bone resorption can also suppress the development of metastatic bone lesions. Less

  • Research Products

    (42 results)

All Other

All Publications (42 results)

  • [Publications] Yamashita,N.,Ogata,E.,etal: "Inhibition of inwardly rectifying K^+ current by external Ca^<2+> ions in freshly isolated rabbit osteoclasts." J.Physiol.480. 217-224 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fukumoto,S.,Ogata,E.,etal.: "Treatment of Malignancy-Associated Hypercalcemia with YM175,a New Bisphosphonate : Elevated Threshold for Parathyroid Hormone Secretion in Hypercalcemic Patients." J.Clin.Endocrinol.Metabol.79. 165-170 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takahashi,S.,etal.: "Cloning and Identification of Annexin II as an Autocrine/Paracrine Factor that Increases Osteoclast Formation and Bone Resorption." J.Biol.Chem.269. 28696-28701 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takahashi,S.,etal.: "Downregulation of Calcitonin Receptor mRNA Expression by Calcitonin during Human Osteoclast-like Cell Differentiation." J.Chin.Invest.95. 167-171 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamato,H.,Ogata,E.,etal.: "In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early state of humoral hypercalcemia of cancer." J.Bone Miner.Res.10(1). 36-44 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ikeda,K.,Ogata,E.,etal.: "Parathyroid hormone-related peptide in hypercalcemia associated with a adult T cell leukemia/Iymphoma : Molecular and cellular mechanism of parathyroid hormone-related peptide overexpression in HTLV-1-infected T cells." Miner.Electrol.Metab.21. 166-170 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koizumi,M.,Ogata,E.,etal: "Bone metabolic markers in bone metastasis." J.Cancer Res.Clin.Oncol.121. 542-548 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takeuchi,T.,Matsumoto,T.,etal: "Relationship between actions of transforming growth factor (TGF)-b and cell surface expression of its receptors in clonal osteoblastic cells." J.Cell.Physiol.162(3). 315-321 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takahashi,K.,Matsumoto,T.,etal.: "Parathyroid hormone-related peptide as a locally produced vasorelaxant : Regulation of its mRNA by hypertension in rats." Biochem.Biophys.Res.Commun.208(1). 447-455 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hata,K.,Matsumoto,T.,etal: "Assay of serum pyridinoline : A potential marker for bone resorption." Clinica Chimica Acta. 235. 221-227 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takahashi,S.,etal.: "Development and Characterization of a Human Marrow Stromal Cell Line That Enhances Osteoclast-like Cell Formation." Endocrinology. 136(4). 1441-1449 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fujita,H.,Ogata,E.,etal: "Activation of Cl-channels by extracellular Ca^<2+> in freshly isolated rabbit osteoclasts." J.Cell.Physiol.169(4). 217-225 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakayama,K.,Ogata,E.,etal: "Differences in bone and vitamin D metabolism between primary hyperparathyroidisrn and malignancy-associated hypercalcemia." J.Clin.Endocrinol.Metab.81(2). 607-611 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fukumoto,S.,Ogata,E.,etal: "Absence of mutations in parathyroid hormone (PTH) /PTH-related protein receptor cDNA in patients with psuedohypoparathyroidism type Ib." J.Clin.Endocrinol.Metab.81(7). 2554-2558 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koizumi,M.,Ogata,E.: "Bisphosphonate Effect on Bone Scintigraphy." J.Nucl.Med.37(2). 401- (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koizumi,M.,Ogata,E.,etal.: "Efficacy of YM-175,a New Bisphosphonate in the Treatment of Metastatic Bone Tumor from Breast Cancer and Its Effect on Scintigraphy." Int.J.Clin.Oncol.1. 18-22 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Chung,U..I.,Ogata,E.,etal.: "The Interaction between Ku Antigen and REFl Protein Mediates Negative Gene Regulatory by Extracellular Calcium." J.Biol.Chem.271(15). 8593-8598 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Chen,J.T.,Ogata,E.,etal.: "Serum N-Terminal Osteocalcin Is a Good Indicator for Estimating Responders to Hormone Replacement Therapy in Postmenopausal Women." J.Bone Miner.Res.11(11). 1784-1792 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maeda,H.,Ogata,E.,etal.: "Correlation between bone metabolic markers and bone scan in prostatic cancer." J.Urolog.157. 539-543 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ogata,E.: "The Potential Use of Vitamin D Analogs in the Treatment of Cancer." Calcif.Tissue Int.60. 130-133 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fuse,H.,Ogata,E.,etal.: "A new synthesic steroid,osaterone acetate (TZP-4238),increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats." J.Bone Miner.Res.12(4). 590-597 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamashita, N., Ishii, T., Ogata, E., Matsumoto, T.: "Inhibition of inwardly rectifying K^+ current by external Ca^<2+> ions in freshly isolated rabbit osteoclasts." J.Physiol.480(2). 217-224 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fukumoto, S., Matsumoto, T., Takabe, K., Onaya T., Eto, S., Nawata, H., Ogata, E.: "Treatment of Malignancy-Associated Hypercalcemia with YM175, a New Bisphosphonate : Elevated Threshold for Parathyroid Hormone Secretion in Hypercalcemic Patients." J.Clin.Endocrinol.Metab.79(1). 164-170 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takahashi, S., Reddy, S.V., Chirgwen, J.M., Devlin, R., Haipek, C., Anderson, J., Roodman, G.D.: "Cloning and Identification of Annexin II as an Autocrine/Paracrine Factor that Increases Osteoclast Formation and Bone Resorption." J.Biol.Chem.269. 28696-28701 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takahashi, S., Golding, S., Katz, M., Hilsenbeck, S., Williams, R., Roodman, G.D.: "Downregulation of Calcitonin Receptor mRNA Expression by Calctonin during Human Osteoclast-like Cell Differentiation." J.Clin.Invest.95. 167-171 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamato, H., Nagai, Y., Inoue, D., Ohnishi, Y., Ueyama, Y., Ohno, H., Matsumoto, T., Ogata, E., Ikeda, K.: "In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early state of humoral hypercalcemia of cancer." J.Bone Min.Res.10(1). 36-44 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ikeda, K., Inoue, D., Okazaki, T., Kikuchi, T., Ogata, E., Matsumoto, T.: "Parathyroid hormone-related peptide in hypercalcemia associated with a adult T cell leukemia/lymphoma : Molecular and cellular mechanism of parathyroid hormone-related peptide overexpression in HTLV-1-infected T cells." Miner.Electrolyte Metab.21. 166-170 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koizumi, M., Yamada, Y., Takiguchi, T., Nomura, E., Furukawa, M., Kitahara, T., Yamashita, T., Maeda, H., Takahashi, S., Aiba, K., Ogata, E.: "Bone metabolic markers in bone metastasis." J.Cancer Res.Clin.Oncol.121. 542-548 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takeuchi, Y., Fukumoto, S., Matsumoto, T.: "Relationship between actions of transforming growth factor (TGF)-b and cell surface exxpression of its receptors in clonal osteoblastic cells." J.Cell Physiol.162(3). 315-321 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takahashi, K., Inoue, D., Ando, K., Matsumoto, T., Ikeda, K., Fujita, T.: "Parathyroid hormone-related peptide as a locally produced vasorelaxant : Regulation of its mRNA by hypertension in rats." Biochem.Biophys.Res.Commun.208(1). 447-455 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hata, K., Miura, M., Fukumoto, S., Matsumoto, T.: "Assay of serum pyridinoline : A potential marker for bone resorption." Clinica Chimica Acta. 235. 221-227 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takahashi, S., Reddy, S.V., Dallas, M., Devlin, R., Chou, J.Y., Roodman, G.D.: "Deveiopment and Characterization of a Human Marrow Stromal Cell Line That Enhances Osteoclast-like Cell Formation." Endocrinology. 136(4). 1441-1449 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koizumi, M., Ogata, E.: "Bisphosphonate Effect on Bone Scintigraphy." J.Nucl.Med.37(2). 401 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakayama, K., Fukumoto, S., Takeda, S., Takeuchi, Y., Ishikawa, T., Miura, M., Hata, K., Hane, M., Tamura, Y., Tanaka, Y., Kitaoka, M., Obara, T., Ogata, E., Matsumoto, T.: "Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia." J.Clin.Endocrinol.Metab.81(2). 607-611 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koizumi, M., Sekine, H., Aoki, M., Hayashi, S., Yamashita, T., Oyamada, H., Ogata, E.: "Efficacy of YM-175, a New Bisphosphonate in the Tretment of Metastatic Bone Tumor from BreastCancer and Its Effect on Scintigraphy." Int.J.Clin.Oncol.1. 18-22 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Chung, U.-I., Igarashi, T., Nishishita, T., Iwanari, H., Iwamatsu, A., Suwa, A., Mimori, T., Hata, K., Ebisu, S., Ogata, E., Fujita, T., Okazaki, T.: "The Interaction between Ku Antigen and REF1 Protein Mediates Negative Gene Regulatory by Extracellular Calcium." J.Biol.Chem.271(15). 8593-8598 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Chen, J.-T., Hosoda, K., Hasumi, K., Ogata, E., Shiraki M.: "Serum N-Terminal Osteocalcin Is a good Indicator for Estimating Responders to Hormone Replacement Therapy in Postmenopausal Women." J.Bone Miner.Res.11(11). 1784-1792 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fukumoto, S., Suzawa, M., Takeuchi, Y., Kodama, Y., Nakayama, K., Ogata, E., Matsumoto, T., Fujita, T.: "Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor cDNA in patients with psuedohypoparathyroidism type Ib." J.Clin.Endocrinol.Metab.81(7). 2554-2558 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fujita, H., Matsumoto, T., Kawashima, H., Ogata, E., Fujita, T., Yamashita, N.: "Activation of Cl-channels by extracellular Ca^<2+> in freshly isolated rabbit osteoclasts." J.Cell Biol.169. 217-225 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeda, H., Koizumi, M., Yoshimura, K., Yamauchi, T., Kawai, T., Ogata, E.: "Correlation between bone metabolic markers and bone scan in prostatic cancer." J.Urolog.157. 539-543 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ogata, E.: "The Potential Use of Vitamin D Analogs in the Tratment of Cancer." Calcif.Tissue Int.60. 130-133 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fuse, H., Fukumoto, S., Sone, H., Miyata, Y., Saito, T., Nakayama, K., Takahashi, H., Matsumoto, T., Ogata, E.: "A New Synthetic Steroid, Osaterone Acetate (TZP-4238), Increases Cortical Bone Mass and Strength by Enhancing Bone Formation in Overiectomized Rats." J.Bone Min.Res.12(4). 590-597 (1997)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi